R&G PharmaStudies Co., Ltd. (SHE:301333)
China
· Delayed Price · Currency is CNY 63.47
-2.36 (-3.58%)
At close: Apr 29, 2026
R&G PharmaStudies Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,093 | 5,666 | 4,756 | 6,190 | 4,940 | - | Upgrade
|
| Market Cap Growth | 20.83% | 19.12% | -23.17% | 25.30% | - | - | Upgrade
|
| Enterprise Value | 4,424 | 3,960 | 3,124 | 4,564 | 3,498 | - | Upgrade
|
| Last Close Price | 63.47 | 59.55 | 49.83 | 63.89 | 50.84 | - | Upgrade
|
| PE Ratio | 45.29 | 41.39 | 33.92 | 38.09 | 43.55 | - | Upgrade
|
| Forward PE | 36.69 | 33.13 | 25.30 | - | - | - | Upgrade
|
| PS Ratio | 6.80 | 6.66 | 6.39 | 8.58 | 7.75 | - | Upgrade
|
| PB Ratio | 3.04 | 2.87 | 2.59 | 3.53 | 3.10 | - | Upgrade
|
| P/TBV Ratio | 3.21 | 3.04 | 2.75 | 3.58 | 3.14 | - | Upgrade
|
| P/FCF Ratio | 68.82 | 59.68 | 35.29 | 35.85 | 45.06 | - | Upgrade
|
| P/OCF Ratio | 56.77 | 49.61 | 30.73 | 32.15 | 37.87 | - | Upgrade
|
| EV/Sales Ratio | 4.94 | 4.65 | 4.20 | 6.33 | 5.49 | - | Upgrade
|
| EV/EBITDA Ratio | 31.40 | 30.62 | 21.64 | 29.69 | 31.68 | - | Upgrade
|
| EV/EBIT Ratio | 35.48 | 32.32 | 25.81 | 34.81 | 33.97 | - | Upgrade
|
| EV/FCF Ratio | 49.97 | 41.72 | 23.18 | 26.43 | 31.90 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.01 | 0.04 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.13 | 0.46 | 0.05 | 0.13 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.48 | 0.19 | 0.53 | 0.05 | 0.14 | 0.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.84 | -0.88 | -0.93 | -0.97 | -0.94 | -0.80 | Upgrade
|
| Net Debt / EBITDA Ratio | -13.16 | -13.38 | -11.81 | -11.03 | -13.64 | -2.59 | Upgrade
|
| Net Debt / FCF Ratio | -18.94 | -18.22 | -12.65 | -9.82 | -13.74 | -4.60 | Upgrade
|
| Asset Turnover | 0.38 | 0.36 | 0.34 | 0.37 | 0.50 | 1.01 | Upgrade
|
| Inventory Turnover | 9.47 | 8.94 | 8.04 | 8.33 | 8.36 | 10.43 | Upgrade
|
| Quick Ratio | 5.83 | 5.44 | 4.73 | 6.20 | 6.25 | 2.35 | Upgrade
|
| Current Ratio | 6.01 | 5.60 | 4.88 | 6.38 | 6.45 | 2.58 | Upgrade
|
| Return on Equity (ROE) | 6.96% | 7.26% | 7.90% | 9.73% | 11.24% | 25.91% | Upgrade
|
| Return on Assets (ROA) | 3.33% | 3.23% | 3.43% | 4.14% | 5.03% | 11.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 38.63% | 57.84% | 113.70% | 159.47% | 104.63% | 136.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 6.10% | 6.40% | 7.50% | 6.40% | 24.60% | Upgrade
|
| Earnings Yield | 2.19% | 2.42% | 2.95% | 2.63% | 2.30% | - | Upgrade
|
| FCF Yield | 1.45% | 1.68% | 2.83% | 2.79% | 2.22% | - | Upgrade
|
| Dividend Yield | 0.24% | 0.27% | 0.32% | 0.31% | 0.31% | - | Upgrade
|
| Payout Ratio | 12.56% | 8.61% | 20.24% | 3.58% | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.16% | -0.36% | 0.64% | -16.78% | -14.43% | 0.38% | Upgrade
|
| Total Shareholder Return | 0.40% | -0.09% | 0.96% | -16.46% | -14.12% | 0.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.